Immunologic response of sarcoidosis

Seminars in Respiratory and Critical Care Medicine

Volumn 31, Issue 4, 2010, Pages 390-403

  Zissel, Gernot ^a   Prasse, Antje ^a   Müller Quernheim, Joachim ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

dendritic cells; granulomatous; innate immunity; lymphocytes; macrophages; Sarcoidosis

Indexed keywords

ANTIGEN PRESENTING CELL; DENDRITIC CELL; DISEASE PREDISPOSITION; GRANULOCYTE; GRANULOMA; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MACROPHAGE; NEUTROPHIL; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; T LYMPHOCYTE; ANIMAL; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; LUNG ALVEOLUS MACROPHAGE; PROGNOSIS;

ANTIGEN; CHEMOKINE; CYTOKINE;

ANIMALS; ANTIGENS; CHEMOKINES; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MACROPHAGES, ALVEOLAR; POLYMORPHISM, GENETIC; PROGNOSIS; SARCOIDOSIS; T-LYMPHOCYTES;

EID: 77955025578     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0030-1262208     Document Type: Review

References (132)

1. Schürmann M. Genetics of sarcoidosis. Semin Respir Crit Care Med 2003 24 213-222
2. Rybicki B A., Hirst K, Iyengar S K. et al. A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study. Sarcoidosis Vasc Diffuse Lung Dis 2005 22 115-122
3. Müller-Quernheim J, Schürmann M, Hofmann S et al. Genetics of sarcoidosis. Clin Chest Med 2008 29 391-414, viii
4. Bianchi M E. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007 81 1-5
5. Manfredi A A., Capobianco A, Bianchi M E., Rovere-Querini P. Regulation of dendritic- and T-cell fate by injury-associated endogenous signals. Crit Rev Immunol 2009 29 69-86
6. Pechkovsky D V., Zalutskaya O M., Ivanov G I., Misuno N I. Calprotectin (MRP8/14 protein complex) release during mycobacterial infection in vitro and in vivo. FEMS Immunol Med Microbiol 2000 29 27-33
7. Bargagli E, Olivieri C, Prasse A et al. Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases. Inflammation 2008 31 351-354
8. Veress B, Malmskld K. The distribution of S100 and lysozyme immunoreactive cells in the various phases of granuloma development in sarcoidosis. Sarcoidosis 1987 4 33-37
9. Ashitani J, Matsumoto N, Nakazato M. Elevated alpha-defensin levels in plasma of patients with pulmonary sarcoidosis. Respirology 2007 12 339-345
10. Paone G, Lucantoni G, Leone A et al. Human neutrophil peptides stimulate tumor necrosis factor-alpha release by alveolar macrophages from patients with sarcoidosis. Chest 2009 135 586-587
11. Chen E S., Song Z, Willett M H. et al. Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am J Respir Crit Care Med 2010 181 360-373 [Epub ahead of print]
12. Pechkovsky D V., Zissel G, Ziegenhagen M W. et al. Effect of proinflammatory cytokines on interleukin-8 mRNA expression and protein production by isolated human alveolar epithelial cells type II in primary culture. Eur Cytokine Netw 2000 11 618-625
13. Larsen C G., Anderson A O., Oppenheim J J., Matsushima K. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology 1989 68 31-36 (Pubitemid 19236065)
14. Sugiyama K, Mukae H, Ishii H et al. Elevated levels of interferon gamma-inducible protein-10 and epithelial neutrophil-activating peptide-78 in patients with pulmonary sarcoidosis. Respirology 2006 11 708-714
15. Ziegenhagen M W., Schrum S, Zissel G, Zipfel P F., Schlaak M, Müller-Quernheim J. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. J Investig Med 1998 46 223-231
16. Car B D., Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G, Walz A. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 1994 149 (3 Pt 1) 655-659
17. Tutor-Ureta P, Citores M J., Castejn R et al. Prognostic value of neutrophils and NK cells in bronchoalveolar lavage of sarcoidosis. Cytometry B Clin Cytom 2006 70 416-422
18. Ziegenhagen M W., Rothe M E., Schlaak M, Müller-Quernheim J. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 2003 21 407-413
19. Borz R M., Grigolo B, Meliconi R et al. Elevated serum superoxide dismutase levels correlate with disease severity and neutrophil degranulation in idiopathic pulmonary fibrosis. Clin Sci (Lond) 1993 85 353-359
20. Rottoli P, Magi B, Cianti R et al. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 2005 5 2612-2618 (Pubitemid 40966488)
21. Lenz A G., Costabel U, Maier K L. Oxidized BAL fluid proteins in patients with interstitial lung diseases. Eur Respir J 1996 9 307-312
22. Müller-Quernheim J, Pfeifer S, Mnnel D, Strausz J, Ferlinz R. Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 1992 145 187-192
23. Ziegenhagen M W., Müller-Quernheim J. The cytokine network in sarcoidosis and its clinical relevance. J Intern Med 2003 253 18-30
24. Wahlstrm J, Berlin M, Skld C M., Wigzell H, Eklund A, Grunewald J. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 1999 54 339-346
25. Bachwich P R., Lynch J P. III, Larrick J W., Spengler M, Kunkel S L. Tumor necrosis factor production by human sarcoid alveolar macrophages. Am J Pathol 1986 125 421-425
26. Wikn M, Grunewald J, Eklund A, Wahlstrm J. Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis. J Clin Immunol 2009 29 78-89
27. Oswald-Richter K A., Culver D A., Hawkins C et al. Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis. Infect Immun 2009 77 3740-3748
28. Pathak S K., Basu S, Basu K K. et al. Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat Immunol 2007 8 610-618
29. Murphy E E., Terres G, Macatonia S E. et al. B7 and interleukin 12 cooperate for proliferation and interferon production by mouse T helper clones that are unresponsive to B7 costimulation. J Exp Med 1994 180 223-231
30. Song Z, Marzilli L, Greenlee B M. et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005 201 755-767
31. Grosser M, Dittert D D., Luther T. Re: Molecular detection of M. tuberculosis DNA in tuberculosis and sarcoidosis. Diagn Mol Pathol 2001 10 66-68
32. Eishi Y, Suga M, Ishige I et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 2002 40 198-204
33. Hiramatsu J, Kataoka M, Nakata Y et al. Propionibacterium acnes DNA detected in bronchoalveolar lavage cells from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003 20 197-203
34. Tanabe T, Ishige I, Suzuki Y et al. Sarcoidosis and NOD1 variation with impaired recognition of intracellular Propionibacterium acnes. Biochim Biophys Acta 2006 1762 (9) 794-801
35. de Rochemonteix-Galve B, Dayer J M., Junod A F. Fibroblast-alveolar cell interactions in sarcoidosis and idiopathic pulmonary fibrosis: evidence for stimulatory and inhibitory cytokine production by alveolar cells. Eur Respir J 1990 3 (6) 653-664
36. Baughman R P., Strohofer S A., Buchsbaum J, Lower E E. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J Lab Clin Med 1990 115 36-42
37. Zheng L, Teschler H, Guzman J, Hübner K, Striz I, Costabel U. Alveolar macrophage TNF- release and BAL cell phenotypes in sarcoidosis. Am J Respir Crit Care Med 1995 152 1061-1066
38. Fehrenbach H, Zissel G, Goldmann T et al. Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis. Eur Respir J 2003 21 421-428
39. Hnsch H C., Smith D A., Mielke M E., Hahn H, Bancroft G J., Ehlers S. Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells. Int Immunol 1996 8 1299-1310
40. Smith D, Hnsch H, Bancroft G, Ehlers S. T-cell-independent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factor-alpha and interferon-gamma. Immunology 1997 92 413-421
41. Lammas D A., De Heer E, Edgar J D. et al. Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway. Int J Exp Pathol 2002 83 1-20
42. Pechkovsky D V., Goldmann T, Vollmer E, Müller-Quernheim J, Zissel G. Interleukin-18 expression by alveolar epithelial cells type II in tuberculosis and sarcoidosis. FEMS Immunol Med Microbiol 2006 46 30-38
43. Shigehara K, Shijubo N, Ohmichi M et al. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 2001 166 642-649
44. Moller D R., Forman J D., Liu M C. et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996 156 4952-4960
45. Zissel G, Prasse A, Müller-Quernheim J. Sarcoidosisimmunopathogenetic concepts. Semin Respir Crit Care Med 2007 28 3-14
46. Dustin M L. Coordination of T cell activation and migration through formation of the immunological synapse. Ann N Y Acad Sci 2003 987 51-59
47. Yarbrough W C. Jr, Wilkes D S., Weissler J C. Human alveolar macrophages inhibit receptor-mediated increases in intracellular calcium concentration in lymphocytes. Am J Respir Cell Mol Biol 1991 5 411-415
48. Ettensohn D B., Lalor P A., Roberts N J. Jr. Human alveolar macrophage regulation of lymphocyte proliferation. Am Rev Respir Dis 1986 133 1091-1096
49. Lem V M., Lipscomb M F., Weissler J C. et al. Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation. J Immunol 1985 135 1766-1771
50. Venet A, Hance A J., Saltini C, Robinson B WS, Crystal R G. Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis. J Clin Invest 1985 75 293-301
51. Ina Y, Takada K, Yamamoto M, Morishita M, Miyachi A. Antigen-presenting capacity in patients with sarcoidosis. Chest 1990 98 911-916
52. Zissel G, Ernst M, Schlaak M, Müller-Quernheim J. Accessory function of alveolar macrophages from patients with sarcoidosis and other granulomatous and nongranulomatous lung diseases. J Investig Med 1997 45 75-86 (Pubitemid 127453340)
53. Poulter L W. Changes in lung macrophages during disease. FEMS Microbiol Immunol 1990 2 327-331
54. Rossi G A., Zocchi E, Sacco O, Balbi B, Ravazzoni C, Damiani G. Alveolar macrophage stimulation of T-cell proliferation in autologous mixed lymphocyte reactions. Role of HLA-DR antigens. Am Rev Respir Dis 1986 133 78-82
55. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997 156 1601-1605
56. Martinetti M, Luisetti M, Cuccia M. HLA and sarcoidosis: new pathogenetic insights. Sarcoidosis Vasc Diffuse Lung Dis 2002 19 83-95
57. Schürmann M, Bein G, Kirsten D, Schlaak M, Müller-Quernheim J, Schwinger E. HLA-DQB1 and HLA-DPB1 genotypes in familial sarcoidosis. Respir Med 1998 92 649-652
58. Hoshino T, Itoh K, Gouhara R et al. Spontaneous production of various cytokines except IL-4 from CD4+ T cells in the affected organs of sarcoidosis patients. Clin Exp Immunol 1995 102 399-405
59. Nicod L P., Isler P, Isler P. Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L. Am J Respir Cell Mol Biol 1997 17 91-96
60. Kaneko Y, Kuwano K, Kunitake R et al. Immunohistochemical localization of B7 costimulating molecules and major histocompatibility complex class II antigen in pulmonary sarcoidosis. Respiration 1999 66 343-348
61. Agostini C, Trentin L, Perin A et al. Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process. Am J Physiol 1999 277 (2 Pt 1) L240-L250
62. Zissel G, Ernst M, Schlaak M, Müller-Quernheim J. Pharmacological modulation of the IFNgamma-induced accessory function of alveolar macrophages and peripheral blood monocytes. Inflamm Res 1999 48 662-668
63. Nicod L P., el Habre F. Adhesion molecules on human lung dendritic cells and their role for T-cell activation. Am J Respir Cell Mol Biol 1992 7 207-213
64. Nguyen T, Liu X K., Zhang Y, Dong C. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. J Immunol 2006 176 7354-7360
65. Valentonyte R, Hampe J, Huse K et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005 37 357-364
66. Li Y, Wollnik B, Pabst S et al. BTNL2 gene variant and sarcoidosis. Thorax 2006 61 273-274
67. Rybicki B A., Walewski J L., Maliarik M J., Kian H, Iannuzzi M C., ACCESS Research Group. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 2005 77 491-499
68. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003 3 23-35
69. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004 25 677-686
70. Prasse A, Pechkovsky D V., Toews G B. et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med 2006 173 781-792
71. Bargagli E, Margollicci M, Luddi A et al. Chitotriosidase activity in patients with interstitial lung diseases. Respir Med 2007 101 2176-2181 (Pubitemid 47324238)
72. Bargagli E, Bianchi N, Margollicci M et al. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity. Scand J Clin Lab Invest 2008 68 479-483
73. Lommatzsch M, Bratke K, Bier A et al. Airway dendritic cell phenotypes in inflammatory diseases of the human lung. Eur Respir J 2007 30 878-886
74. Munro C S., Campbell D A., Du Bois R M., Mitchell D N., Cole P J., Poulter L W. Dendritic cells in cutaneous, lymph node and pulmonary lesions of sarcoidosis. Scand J Immunol 1987 25 461-467
75. van Haarst J M., Verhoeven G T., de Wit H J., Hoogsteden H C., Debets R, Drexhage H A. CD1a+ and CD1a accessory cells from human bronchoalveolar lavage differ in allostimulatory potential and cytokine production. Am J Respir Cell Mol Biol 1996 15 752-759
76. Mathew S, Bauer K L., Fischoeder A, Bhardwaj N, Oliver S J. The anergic state in sarcoidosis is associated with diminished dendritic cell function. J Immunol 2008 181 746-755
77. Kulakova N, Urban B, McMichael A J., Ho L P. Functional analysis of dendritic cell-T cell interaction in sarcoidosis. Clin Exp Immunol 2010 159 82-86
78. Gibejova A, Mrazek F, Subrtova D et al. Expression of macrophage inflammatory protein-3 beta/CCL19 in pulmonary sarcoidosis. Am J Respir Crit Care Med 2003 167 1695-1703
79. Facco M, Baesso I, Miorin M et al. Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis. J Leukoc Biol 2007 82 946-955
80. Holter J F., Park H K., Sjoerdsma K W., Kataria Y P. Nonviable autologous bronchoalveolar lavage cell preparations induce intradermal epithelioid cell granulomas in sarcoidosis patients. Am Rev Respir Dis 1992 145 (4 Pt 1) 864-871
81. Katchar K, Sderstrm K, Wahlstrom J, Eklund A, Grunewald J. Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients. Eur Respir J 2005 26 77-85
82. Robinson B W., Pinkston P, Crystal R G. Natural killer cells are present in the normal human lung but are functionally impotent. J Clin Invest 1984 74 942-950
83. Du Bois R M., Kirby M, Balbi B, Saltini C, Crystal R G. T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T-cell antigen receptor. Am Rev Respir Dis 1992 145 1205-1211
84. Müller-Quernheim J, Saltini C, Sondermeyer P, Crystal R G. Compartmentalized activation of the interleukin 2 gene by lung T lymphocytes in active pulmonary sarcoidosis. J Immunol 1986 137 3475-3483 (Pubitemid 17193303)
85. Devergne O, Emilie D, Peuchmaur M, Crevon M C., DAgay M F., Galanaud P. Production of cytokines in sarcoid lymph nodes: preferential expression of interleukin-1 beta and interferon-gamma genes. Hum Pathol 1992 23 317-323
86. Zhu J, Paul W E. CD4 T cells: fates, functions, and faults. Blood 2008 112 1557-1569
87. Agostini C, Cabrelle A, Calabrese F et al. Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. Am J Respir Crit Care Med 2005 172 1290-1298
88. Takeuchi M, Oh-I K, Suzuki J et al. Elevated serum levels of CXCL9/monokine induced by interferon-gamma and CXCL10/interferon-gamma-inducible protein-10 in ocular sarcoidosis. Invest Ophthalmol Vis Sci 2006 47 1063-1068
89. Morgan A J., Guillen C, Symon F A. et al. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clin Exp Allergy 2005 35 1572-1580
90. Capelli A, Di Stefano A, Lusuardi M, Gnemmi I, Donner C F. Increased macrophage inflammatory protein-1alpha and macrophage inflammatory protein-1beta levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis. Am J Respir Crit Care Med 2002 165 236-241
91. Müller-Quernheim J, Krnke M, Strausz J, Schykowski M, Ferlinz R. Interleukin-2 receptor gene expression by bronchoalveolar lavage lymphocytes in pulmonary sarcoidosis. Am Rev Respir Dis 1989 140 82-88
92. Paine R III, Mody C H., Chavis A, Spahr M A., Turka L A., Toews G B. Alveolar epithelial cells block lymphocyte proliferation in vitro without inhibiting activation. Am J Respir Cell Mol Biol 1991 5 221-229
93. Prasse A, Katic C, Germann M, Buchwald A, Zissel G, Müller-Quernheim J. Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med 2008 177 330-336
94. Grutters J C., Fellrath J M., Mulder L, Janssen R, van den Bosch J M., van Velzen-Blad H. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest 2003 124 186-195
95. Rothkrantz-Kos S, van Dieijen-Visser M P., Mulder P G., Drent M. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem 2003 49 1510-1517
96. Müller-Quernheim J, Pfeifer S, Strausz J, Ferlinz R. Correlation of clinical and immunologic parameters of the inflammatory activity of pulmonary sarcoidosis. Am Rev Respir Dis 1991 144 1322-1329
97. Richter E, Kataria Y P., Zissel G, Homolka J, Schlaak M, Müller-Quernheim J. Analysis of the Kveim-Siltzbach test reagent for bacterial DNA. Am J Respir Crit Care Med 1999 159 1981-1984
98. Klein J T., Horn T D., Forman J D., Silver R F., Teirstein A S., Moller D R. Selection of oligoclonal V -specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J Immunol 1995 154 1450-1460
99. Silver R F., Crystal R G., Moller D R. Limited heterogeneity of biased T-cell receptor V beta gene usage in lung but not blood T cells in active pulmonary sarcoidosis. Immunology 1996 88 516-523
100. Zissel G, Bumer I, Fleischer B, Schlaak M, Müller-Quernheim J. TCR V families in T cell clones from sarcoid lung parenchyma, BAL, and blood. Am J Respir Crit Care Med 1997 156 1593-1600
101. Prasse A, Georges C G., Biller H et al. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol 2000 122 241-248
102. Bumer I, Zissel G, Schlaak M, Müller-Quernheim J. Th1/Th2 cell distribution in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 1997 16 171-177
103. Grunewald J, Wahlstrm J, Berlin M, Wigzell H, Eklund A, Olerup O. Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation. Thorax 2002 57 348-352
104. Katchar K, Wahlstrm J, Eklund A, Grunewald J. Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis. Am J Respir Crit Care Med 2001 163 1540-1545
105. Grunewald J, Berlin M, Olerup O, Eklund A. Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosis. Am J Respir Crit Care Med 2000 161 (3 Pt 1) 814-818
106. Chen E S., Wahlstrm J, Song Z et al. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol 2008 181 8784-8796
107. Ishige I, Usui Y, Takemura T, Eishi Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999 354 120-123
108. Nakata Y, Ejiri T, Kishi T et al. Alveolar lymphocyte proliferation induced by Propionibacterium acnes in sarcoidosis patients. Acta Med Okayama 1986 40 257-264
109. Ebe Y, Ikushima S, Yamaguchi T et al. Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2000 17 256-265
110. Kalis C, Gumenscheimer M, Freudenberg N et al. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. J Immunol 2005 174 4295-4300
111. Wahlstrm J, Dengjel J, Persson B et al. Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest 2007 117 3576-3582
112. Wahlstrm J, Dengjel J, Winqvist O et al. Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. Clin Immunol 2009 133 353-363
113. Miyara M, Amoura Z, Parizot C et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006 203 359-370
114. Idali F, Wahlstrm J, Müller-Suur C, Eklund A, Grunewald J. Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis. Clin Exp Immunol 2008 152 127-137
115. Taflin C, Miyara M, Nochy D et al. FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am J Pathol 2009 174 497-508
116. Zissel G, Bumer I, Schlaak M, Müller-Quernheim J. In vitro release of interleukin-15 by broncho-alveolar lavage cells and peripheral blood mononuclear cells from patients with different lung diseases. Eur Cytokine Netw 2000 11 105-112
117. Stridh H, Planck A, Gigliotti D, Eklund A, Grunewald J. Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis. Thorax 2002 57 897-901
118. Zissel G, Homolka J, Schlaak J, Schlaak M, Müller-Quernheim J. Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis. Am J Respir Crit Care Med 1996 154 (3 Pt 1) 713-719
119. Ziegenhagen M W., Benner U K., Zissel G, Zabel P, Schlaak M, Müller-Quernheim J. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med 1997 156 1586-1592
120. Veltkamp M, Wijnen P A., van Moorsel C H. et al. Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol 2007 149 453-462
121. Tsan M F., Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004 76 514-519
122. Ota M, Amakawa R, Uehira K et al. Involvement of dendritic cells in sarcoidosis. Thorax 2004 59 408-413
123. Mllers M, Aries S P., Drmann D, Mascher B, Braun J, Dalhoff K. Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis. Thorax 2001 56 487-493
124. Strausz J, Mnnel D N., Pfeifer S, Borkowski A, Ferlinz R, Müller-Quernheim J. Spontaneous monokine release by alveolar macrophages in chronic sarcoidosis. Int Arch Allergy Appl Immunol 1991 96 68-75
125. Pechkovsky D V., Goldmann T, Ludwig C et al. CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II. Respir Res 2005 6 75
126. Petrek M, Kolek V, Szotkowsk J, du Bois R M. CC and C chemokine expression in pulmonary sarcoidosis. Eur Respir J 2002 20 1206-1212
127. Bergeron A, Bonay M, Kambouchner M et al. Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J Immunol 1997 159 3034-3043
128. Somoskvi A, Zissel G, Zipfel P F. et al. Different cytokine patterns correlate with the extension of disease in pulmonary tuberculosis. Eur Cytokine Netw 1999 10 135-142
129. Zissel G, Schlaak J, Schlaak M, Müller-Quernheim J. Regulation of cytokine release by alveolar macrophages treated with interleukin-4, interleukin-10, or transforming growth factor beta. Eur Cytokine Netw 1996 7 59-66
130. Limper A H., Colby T V., Sanders M S., Asakura S, Roche P C., DeRemee R A. Immunohistochemical localization of transforming growth factor- 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med 1994 149 197-204
131. Marshall B G., Wangoo A, Cook H T., Shaw R J. Increased inflammatory cytokines and new collagen formation in cutaneous tuberculosis and sarcoidosis. Thorax 1996 51 1253-1261
132. Baughman R P., Drent M, Kavuru M et al, Sarcoidosis Investigators. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006 174 795-802